NCT01493856

A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276

A Randomized, Open Label, Single-Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276 in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 58 (actual)
• Sponsor: Daewoong Pharmaceutical Co. LTD. · Industry
• Sex: Male
• Age: 20 Years – 50 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the safety and pharmacokinetic characteristics of combination of rosuvastatin and CS-866 and DWJ1276 alone.

Conditions

• Healthy Volunteers

Interventions

Type	Name	Description
DRUG	Cresto	tablet, rosuvastatin 20mg
DRUG	Olmetec	tablet, olmesartan medoxomil(CS-866) 40mg
DRUG	DWJ1276	tablet, Rosuvastatin 20mg and olmesartan medoxomil 40mg

Timeline

• Start date: 2012-01-01
• Primary completion: 2012-02-01
• Completion: 2012-03-01
• First posted: 2011-12-16
• Last updated: 2012-04-04

Locations

1 site across 1 country: South Korea